Peters Agency Hospice & Pallative Care 926 East Cherokee, Sallisaw, OK, 74955 | |
(918) 775-6555 |
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
Name | Peters Agency Hospice & Pallative Care |
---|---|
Location | 926 East Cherokee, Sallisaw, Oklahoma |
Hospice ID | 371703 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Individual |
Profit Type | FOR PROFIT |
Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
SSA county code | 670 |
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
NPI Number | 1194081547 |
Organization Name | Peters Agency Hospice And Pallitative Care, Llc |
Address | 1015 E. Choctaw Sallisaw, Oklahoma, 74955 |
Phone Number | (918)790-7555 |
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
NPI Number | 1447520820 |
Organization Name | Peters Agency Care Management Llc |
Address | 926 E. Cherokee Sallisaw, Oklahoma, 74955 |
Phone Number | (918)775-6555 |
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
NPI Number | 1871862870 |
Organization Name | Pluma Care Private Duty Services, Llc. |
Address | 926 E. Cherokee Ave. Sallisaw, Oklahoma, 74955 |
Phone Number | (918)775-6555 |
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.4 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.4 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 95.7 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
Home Health Aides | 6 |
Counselors | 1.25 |
Homemakers | 2 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1.25 |
Physicians | 2 |
Registered Nurses | 6 |
Other Personnel | 1 |
Total Employees | 20.5 |
---|
News Archive
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.
Aetna Better Health in Pennsylvania and The Children's Hospital of Philadelphia announced today that they have reached agreement on a new contract that adds the hospital to the Medicaid provider's network in Pennsylvania. The new contract is effective immediately.
A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.
› Verified 8 days ago
Sequoyah County-city Of Sallisaw Hosp Authority Location: 213 East Redwood, Sallisaw, Oklahoma, 74955 Phone: (918) 775-6555 |
Cima Hospice Of Sallisaw Location: 103 North Walnut, Sallisaw, Oklahoma, 74955 Phone: (918) 775-6555 |
Peters Agency Hospice & Pallative Care Location: 926 East Cherokee, Sallisaw, Oklahoma, 74955 Phone: (918) 775-6555 |
Tallgrass Hospice Inc Location: 306 West Inola, Sallisaw, Oklahoma, 74955 Phone: (918) 775-6555 |